These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12498774)

  • 1. Enhanced gene expression in breast cancer cells in vitro and tumors in vivo.
    Lu H; Zhang Y; Roberts DD; Osborne CK; Templeton NS
    Mol Ther; 2002 Dec; 6(6):783-92. PubMed ID: 12498774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
    Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
    J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of plasmid vectors for high-level expression in lung epithelial cells.
    Yew NS; Wysokenski DM; Wang KX; Ziegler RJ; Marshall J; McNeilly D; Cherry M; Osburn W; Cheng SH
    Hum Gene Ther; 1997 Mar; 8(5):575-84. PubMed ID: 9095409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cells.
    Shi CX; Long MA; Liu L; Graham FL; Gauldie J; Hitt MM
    Mol Ther; 2004 Oct; 10(4):758-67. PubMed ID: 15451460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
    Anisowicz A; Sotiropoulou G; Sager R
    Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a plasmid vector for liver-specific inhibition of hepatocyte nuclear factor 4 alpha expression.
    Song XQ; Chen EQ; Wang YB; Zhou TY; Liu L; Liu C; Cheng X; Tang H
    Plasmid; 2012 Jan; 67(1):60-6. PubMed ID: 21907733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.
    Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM
    Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction and expression of recombinant plasmid with prostate-specific membrane antigen promoter and enhancer regulating uracil phosphoribosyltransferase gene].
    Zhao FJ; Li H; Cheng HM; Zeng H; Wei Q; Li X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):172-5. PubMed ID: 15807258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.
    Majumdar S; Diamandis EP
    Br J Cancer; 1999 Mar; 79(9-10):1594-602. PubMed ID: 10188912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel HER2 gene body enhancer contributes to HER2 expression.
    Liu Q; Kulak MV; Borcherding N; Maina PK; Zhang W; Weigel RJ; Qi HH
    Oncogene; 2018 Feb; 37(5):687-694. PubMed ID: 29035388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cells.
    Higashimura Y; Nakajima Y; Yamaji R; Harada N; Shibasaki F; Nakano Y; Inui H
    Arch Biochem Biophys; 2011 May; 509(1):1-8. PubMed ID: 21338575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.
    Day CP; Rau KM; Qiu L; Liu CW; Kuo HP; Xie X; Lopez-Berestein G; Hortobagyi GN; Hung MC
    Cancer Gene Ther; 2006 Jul; 13(7):706-19. PubMed ID: 16514421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancer and promoter chimeras in plasmids designed for intramuscular injection: a comparative in vivo and in vitro study.
    Barnhart KM; Hartikka J; Manthorpe M; Norman J; Hobart P
    Hum Gene Ther; 1998 Nov; 9(17):2545-53. PubMed ID: 9853521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Constructing recombinant plasmid with prostate-specific membrane antigen promoter and reverse enhancer and comparing the transcription activity of enhancers in different directions].
    Zeng H; Liao YC; Wang F; Wu Q; Yang YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 36(6):782-5. PubMed ID: 16334552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
    Tang D; Sivko GS; DeWille JW
    Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
    Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
    Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.
    Guo ZS; Wang LH; Eisensmith RC; Woo SL
    Gene Ther; 1996 Sep; 3(9):802-10. PubMed ID: 8875229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir.
    Manome Y; Abe M; Hagen MF; Fine HA; Kufe DW
    Cancer Res; 1994 Oct; 54(20):5408-13. PubMed ID: 7923173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.